Stephen Doster
-
Study explores how bacteria become drug resistant
Researchers at Vanderbilt University and the University of Arizona have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs. Their findings, which were reported recently in the journal Nature Chemical Biology, will aid the search for inhibitors… Read MoreJan. 6, 2022
-
Vanderbilt extends its longest ongoing drug discovery agreement with pharmaceutical company through 2023
Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. The initial agreement was signed in November… Read MoreDec. 22, 2021
-
Study sets framework for precision surveillance of colorectal cancer
by Tom Wilemon A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Their study, published Dec. 14 in Cell, describes findings from a single-cell transcriptomic and imaging atlas… Read MoreDec. 17, 2021
-
Neutrons take a deep dive into water networks surrounding DNA
By Olivia Trani This article was originally published on the Oak Ridge National Laboratory website and was adapted with permission for publication at Vanderbilt University. Water plays several important roles within the human body, even affecting the DNA in our cells. The entire surface of a DNA… Read MoreDec. 17, 2021
-
Producing green fuel, and more rapid determination of the biological consequences of gene editing
A team of Vanderbilt researchers led by Jamey Young, Cornelius Vanderbilt Professor of Engineering, John McLean, department chair and Stevenson Professor of Chemistry, and Carl Johnson, Cornelius Vanderbilt Professor of Biological Sciences, has described a novel method for rapidly characterizing… Read MoreDec. 15, 2021
-
Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization
On Wednesday, the U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which protects against COVID-19, discovered last year at Vanderbilt University Medical Center (VUMC). A number of medical conditions result in immune compromise, from treatments for many cancers… Read MoreDec. 9, 2021
-
McLean elected as 2021 National Academy of Inventors Fellow
John McLean, Stevenson Professor of Chemistry, Stevenson Chair and the director of the Center for Innovative Technologies, has been elected a 2021 Fellow of the National Academy of Inventors… Read MoreDec. 8, 2021
-
A potential new approach for the treatment of schizophrenia
THE IDEA Jeffrey Conn (John Russell/Vanderbilt University) James Maksymetz A new study led by Jeff Conn, Lee E. Limbird Chair in Pharmacology, James Maksymetz, a former graduate student in the Conn laboratory, and other collaborators at the Warren Center for… Read MoreDec. 8, 2021
-
Deciphering the Circuits in Neuroscience Research
Around 500 million people around the world are affected by poor mental health including disorders such as depression, schizophrenia, bipolar disease and dementia with a significant impact on quality of life as well as associated social and economic consequences.1 Boehringer Ingelheim is dedicated to redefining the management of mental health. Read MoreDec. 7, 2021
-
Flipping the script on flippases
Todd Graham, Stevenson Chair of Biological Sciences and professor of cell and developmental biology, and external collaborators recently published a paper describing the structure of a yeast “flippase” called Neo1. The research was led by three co-first authors: Bhawik Jain, a postdoc from the Graham lab, Lin Bai from Peking… Read MoreDec. 6, 2021